Post written by: BioTech Health X
You May Also Like
Pro-Dex (PDEX) Plunges 39% – Here’s Why Smart Investors Are Buying the Dip
- BioTech Health X
- June 8, 2025
- 5 minute read
Table of Contents Hide A Rollercoaster in Valuation: What the Share Price Pullback MeansEarnings Momentum: From Exceptional Growth…
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In
- BioTech Health X
- May 13, 2021
- 3 minute read
Table of Contents Hide Vaccinated Players, Positive Tests85% Fully Vaccinated Staff Pushes ForwardVirology Experts Weigh In on Yankees…
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
- BioTech Health X
- July 28, 2022
- 3 minute read
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
- BioTech Health X
- July 20, 2022
- 3 minute read
Table of Contents Hide About BrickellWhat This Means for Brickell Biotech ShareholdersUnderstanding Nasdaq Minimum Bid Price RequirementWhy Nasdaq…
Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
- BioTech Health X
- August 1, 2022
- 3 minute read
Table of Contents Hide About Krystal Biotech’s KB407KB407 Phase 1 Trial OverviewCystic Fibrosis OverviewAbout Krystal Biotech, Inc. Leader…
Prostate Cancer Breakthrough: Candel Therapeutic (CADL)’s CAN-2409 Trials Near Completion
- BioTech Health X
- December 27, 2024
- 4 minute read
Table of Contents Hide Advancing CAN-2409: A Game-Changer for Prostate Cancer TreatmentCAN-3110: Expanding Horizons in Cancer ImmunotherapyenLIGHTEN™ Discovery…